Abstract:As scientific understandings of genetics advance, researchers require increasingly rich datasets that combine genomic data from large numbers of individuals with medical and other personal information. Linking individuals' genetic data and personal information precludes anonymity and produces medically significant information--a result not contemplated by the established legal and ethical conventions governing human genomic research. To pursue the next generation of human genomic research and commerce in a responsible fashion, scientists, lawyers, and regulators must address substantial new issues, including researchers' duties with respect to clinically significant data, the challenges to privacy presented by genomic data, the boundary between genomic research and commerce, and the practice of medicine. This Article presents a new model for understanding and addressing these new challenges--a "public genomics" premised on the idea that ethically, legally, and socially responsible genomics research requires openness, not privacy, as its organizing principle. Responsible public genomics combines the data contributed by informed and fully consenting information altruists and the research potential of rich datasets in a genomic commons that is freely and globally available. This Article examines the risks and benefits of this public genomics model in the context of an ambitious genetic research project currently under way--the Personal Genome Project. This Article also (i) demonstrates that large-scale genomic projects are desirable, (ii) evaluates the risks and challenges presented by public genomics research, and (iii) determines that the current legal and regulatory regimes restrict beneficial and responsible scientific inquiry while failing to adequately protect participants. The Article concludes by proposing a modified normative and legal framework that embraces and enables a future of responsible public genomics.

Adopt a Moratorium on Heritable Genome Editing

Human heritable genome editing and its governance: views of scientists and governance professionals

Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing

Human Germline Genome Editing

Recent Developments in the Regulation of Heritable Human Genome Editing

The NIH Somatic Cell Genome Editing program

Are null segregants new combinations of heritable material and should they be regulated?

Genome Editing Dilemma: Navigating Dual-Use Potential and Charting the Path Forward

Focusing on Human Rights: a framework for CRISPR germline genome editing ethics and regulation

A society-wide conversation is needed about germline genome editing using CRISPR

UK Scientists Reject Call for Moratorium on Gene Editing

Debating Ethical Issues in Genome Editing Technology

Germline genome editing of human IVF embryos should not be subject to overly stringent restrictions

Emerging ethical perspectives in the clustered regularly interspaced short palindromic repeats genome-editing debate

Making genome editing a success story in Africa

Genome Editing for Longer Lives: The Problem of Loneliness

Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi

Gene editing: the risks and benefits of modifying human DNA

Enabling responsible public genomics

The public-private research ecosystem in the genome editing era

Toward unrestricted use of public genomic data